Principal Financial Group Inc Ngm Biopharmaceuticals Inc Transaction History

Principal Financial Group Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	BUY	$1.17 - $1.92 $906 - $1,488	775 Added 4.07%	19,796 $31,000
Q4 2023 Feb 07, 2024	SELL	$0.6 - $1.31 $958 - $2,093	-1,598 Reduced 7.75%	19,021 $16,000
Q2 2023 Aug 07, 2023	BUY	$2.44 - $4.53 $6,548 - $12,158	2,684 Added 14.97%	20,619 $53,000
Q1 2023 May 09, 2023	SELL	$3.72 - $5.4 $2,856 - $4,147	-768 Reduced 4.11%	17,935 $73,000
Q4 2022 Feb 09, 2023	BUY	$3.41 - $12.93 $15,880 - $60,215	4,657 Added 33.16%	18,703 $93,000
Q3 2022 Nov 09, 2022	BUY	$12.59 - $17.67 $10,777 - $15,125	856 Added 6.49%	14,046 $184,000
Q2 2022 Aug 10, 2022	BUY	$10.58 - $17.5 $139,550 - $230,825	13,190 New	13,190 $169,000
Q4 2021 Feb 09, 2022	SELL	$17.26 - $22.02 $252,479 - $322,108	-14,628 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$20.15 - $26.19 $47,775 - $62,096	-2,371 Reduced 13.95%	14,628 $307,000
Q2 2021 Aug 10, 2021	BUY	$15.06 - $30.03 $25,722 - $51,291	1,708 Added 11.17%	16,999 $335,000
Q1 2021 May 10, 2021	BUY	$24.99 - $31.93 $26,914 - $34,388	1,077 Added 7.58%	15,291 $445,000
Q4 2020 Feb 08, 2021	SELL	$16.21 - $31.44 $565,145 - $1.1 Million	-34,864 Reduced 71.04%	14,214 $431,000
Q3 2020 Nov 06, 2020	BUY	$15.59 - $19.97 $251,918 - $322,695	16,159 Added 49.09%	49,078 $780,000
Q2 2020 Aug 05, 2020	BUY	$11.97 - $23.47 $394,040 - $772,608	32,919 New	32,919 $650,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.